aluates Reports

$ 0.0

Automative

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-30N15963

$Global Latex Particle Enhanced Turbidimetric Immunoassay PETIA Market Research Report 2023$

BUY CHAPTERS

Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Research Report 2025

Code: QYRE-Auto-30N15963

Report

May 2025

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gentian Diagnostics

Thermo Fisher Scientific

BUEHLMANN

Biotec

Abbott Laboratories

Roche

Siemens AG

Danaher Corporation

Diasorin SPA

Sysmex Corporation

Biomerieux

Qiagen NV

Agilent Technologies

Cnpair Biotech

Enriching Biotechnology

Diagvita

Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market

The global market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The latex particle-enhanced immunoturbidimetric immunoassay (PETIA) is a particle-enhanced turbidimetric immunoassay technology that utilizes the particle enhancement effect and combines immunological principles to quantitatively determine the concentration of specific proteins in body fluids. In PETIA, the substance to be detected binds to a specific antibody to form an immune complex, and then latex particles (usually polystyrene particles) with affinity are added, which bind to the immune complex and form clumps. When immune complexes bind to latex particles, a turbid solution results. Next, an optical instrument is used to measure the turbidity of the solution, which is proportional to the concentration of the substance to be measured.

The PETIA technology has the advantages of high sensitivity, easy operation, and high degree of automation. It can be used to measure proteins, hormones, tumor markers in serum, which is of great significance.

This report aims to provide a comprehensive presentation of the global market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA).

The Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Report

Report Metric	Details
Report Name	Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market
Segment by Type	Scattering Nephelometric Detection Method Transmittance Nephelometric Detection Method
Segment by Application	Reagent Instrument Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gentian Diagnostics, Thermo Fisher Scientific, Buehlmann, Biotec, Abbott Laboratories, Roche, Siemens, Danaher Corporation, Diasorin SPA, Sysmex Corporation, Biomerieux, QIAGEN, Agilent Technologies, Cnpair Biotech, Diagvita, Enriching Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market report?

Ans: The main players in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market are Gentian Diagnostics, Thermo Fisher Scientific, Buehlmann, Biotec, Abbott Laboratories, Roche, Siemens, Danaher Corporation, Diasorin SPA, Sysmex Corporation, Biomerieux, QIAGEN, Agilent Technologies, Cnpair Biotech, Diagvita, Enriching Biotechnology

What are the Application segmentation covered in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market report?

Ans: The Applications covered in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market report are Reagent, Instrument, Others

What are the Type segmentation covered in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market report?

Ans: The Types covered in the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market report are Scattering Nephelometric Detection Method, Transmittance Nephelometric Detection Method

Recommended Reports

Veterinary Diagnostics

Animal Health Tests

Latex and Polystyrene

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Scattering Nephelometric Detection Method

1.2.3 Transmittance Nephelometric Detection Method

1.3 Market by Application

1.3.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Reagent

1.3.3 Instrument

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Perspective (2020-2031)

2.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Growth Trends by Region

2.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Region (2020-2025)

2.2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031)

2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Dynamics

2.3.1 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Industry Trends

2.3.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers

2.3.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges

2.3.4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue

3.1.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue (2020-2025)

3.1.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Players (2020-2025)

3.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue

3.4 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio

3.4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024

3.5 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Head office and Area Served

3.6 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application

3.7 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Type

4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Type (2020-2025)

4.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031)

5 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Application

5.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Application (2020-2025)

5.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)

6.2 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)

6.4 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)

7.2 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)

7.4 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)

8.2 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025)

8.4 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)

9.2 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)

9.4 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)

10.2 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)

10.4 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gentian Diagnostics

11.1.1 Gentian Diagnostics Company Details

11.1.2 Gentian Diagnostics Business Overview

11.1.3 Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.1.4 Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.1.5 Gentian Diagnostics Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.2.4 Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Buehlmann

11.3.1 Buehlmann Company Details

11.3.2 Buehlmann Business Overview

11.3.3 Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.3.4 Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.3.5 Buehlmann Recent Development

11.4 Biotec

11.4.1 Biotec Company Details

11.4.2 Biotec Business Overview

11.4.3 Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.4.4 Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.4.5 Biotec Recent Development

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Details

11.5.2 Abbott Laboratories Business Overview

11.5.3 Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.5.4 Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.5.5 Abbott Laboratories Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.6.4 Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Siemens

11.7.1 Siemens Company Details

11.7.2 Siemens Business Overview

11.7.3 Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.7.4 Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.7.5 Siemens Recent Development

11.8 Danaher Corporation

11.8.1 Danaher Corporation Company Details

11.8.2 Danaher Corporation Business Overview

11.8.3 Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.8.4 Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.8.5 Danaher Corporation Recent Development

11.9 Diasorin SPA

11.9.1 Diasorin SPA Company Details

11.9.2 Diasorin SPA Business Overview

11.9.3 Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.9.4 Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.9.5 Diasorin SPA Recent Development

11.10 Sysmex Corporation

11.10.1 Sysmex Corporation Company Details

11.10.2 Sysmex Corporation Business Overview

11.10.3 Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.10.4 Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.10.5 Sysmex Corporation Recent Development

11.11 Biomerieux

11.11.1 Biomerieux Company Details

11.11.2 Biomerieux Business Overview

11.11.3 Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.11.4 Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.11.5 Biomerieux Recent Development

11.12 QIAGEN

11.12.1 QIAGEN Company Details

11.12.2 QIAGEN Business Overview

11.12.3 QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.12.4 QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.12.5 QIAGEN Recent Development

11.13 Agilent Technologies

11.13.1 Agilent Technologies Company Details

11.13.2 Agilent Technologies Business Overview

11.13.3 Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.13.4 Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.13.5 Agilent Technologies Recent Development

11.14 Cnpair Biotech

11.14.1 Cnpair Biotech Company Details

11.14.2 Cnpair Biotech Business Overview

11.14.3 Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.14.4 Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.14.5 Cnpair Biotech Recent Development

11.15 Diagvita

11.15.1 Diagvita Company Details

11.15.2 Diagvita Business Overview

11.15.3 Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.15.4 Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.15.5 Diagvita Recent Development

11.16 Enriching Biotechnology

11.16.1 Enriching Biotechnology Company Details

11.16.2 Enriching Biotechnology Business Overview

11.16.3 Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction

11.16.4 Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

11.16.5 Enriching Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gentian Diagnostics

Thermo Fisher Scientific

BUEHLMANN

Biotec

Abbott Laboratories

Roche

Siemens AG

Danaher Corporation

Diasorin SPA

Sysmex Corporation

Biomerieux

Qiagen NV

Agilent Technologies

Cnpair Biotech

Enriching Biotechnology

Diagvita

List of Tables

Table 1. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Scattering Nephelometric Detection Method

Table 3. Key Players of Transmittance Nephelometric Detection Method

Table 4. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2025)

Table 8. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2026-2031)

Table 10. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Trends

Table 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers

Table 12. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges

Table 13. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints

Table 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players (2020-2025)

Table 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)

Table 17. Ranking of Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Headquarters and Area Served

Table 20. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application

Table 21. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2020-2025)

Table 25. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2026-2031)

Table 27. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2020-2025)

Table 29. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2026-2031)

Table 31. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Gentian Diagnostics Company Details

Table 47. Gentian Diagnostics Business Overview

Table 48. Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 49. Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 50. Gentian Diagnostics Recent Development

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 54. Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Buehlmann Company Details

Table 57. Buehlmann Business Overview

Table 58. Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 59. Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 60. Buehlmann Recent Development

Table 61. Biotec Company Details

Table 62. Biotec Business Overview

Table 63. Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 64. Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 65. Biotec Recent Development

Table 66. Abbott Laboratories Company Details

Table 67. Abbott Laboratories Business Overview

Table 68. Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 69. Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 70. Abbott Laboratories Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 74. Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 75. Roche Recent Development

Table 76. Siemens Company Details

Table 77. Siemens Business Overview

Table 78. Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 79. Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 80. Siemens Recent Development

Table 81. Danaher Corporation Company Details

Table 82. Danaher Corporation Business Overview

Table 83. Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 84. Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 85. Danaher Corporation Recent Development

Table 86. Diasorin SPA Company Details

Table 87. Diasorin SPA Business Overview

Table 88. Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 89. Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 90. Diasorin SPA Recent Development

Table 91. Sysmex Corporation Company Details

Table 92. Sysmex Corporation Business Overview

Table 93. Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 94. Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 95. Sysmex Corporation Recent Development

Table 96. Biomerieux Company Details

Table 97. Biomerieux Business Overview

Table 98. Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 99. Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 100. Biomerieux Recent Development

Table 101. QIAGEN Company Details

Table 102. QIAGEN Business Overview

Table 103. QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 104. QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 105. QIAGEN Recent Development

Table 106. Agilent Technologies Company Details

Table 107. Agilent Technologies Business Overview

Table 108. Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 109. Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 110. Agilent Technologies Recent Development

Table 111. Cnpair Biotech Company Details

Table 112. Cnpair Biotech Business Overview

Table 113. Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 114. Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 115. Cnpair Biotech Recent Development

Table 116. Diagvita Company Details

Table 117. Diagvita Business Overview

Table 118. Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 119. Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 120. Diagvita Recent Development

Table 121. Enriching Biotechnology Company Details

Table 122. Enriching Biotechnology Business Overview

Table 123. Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product

Table 124. Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)

Table 125. Enriching Biotechnology Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Picture

Figure 2. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Type: 2024 VS 2031

Figure 4. Scattering Nephelometric Detection Method Features

Figure 5. Transmittance Nephelometric Detection Method Features

Figure 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Application: 2024 VS 2031

Figure 8. Reagent Case Studies

Figure 9. Instrument Case Studies

Figure 10. Others Case Studies

Figure 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Report Years Considered

Figure 12. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region: 2024 VS 2031

Figure 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players in 2024

Figure 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024

Figure 18. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)

Figure 20. United States Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)

Figure 24. Germany Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2031)

Figure 32. China Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)

Figure 40. Mexico Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)

Figure 44. Turkey Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Gentian Diagnostics Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 49. Buehlmann Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 50. Biotec Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 51. Abbott Laboratories Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 53. Siemens Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 54. Danaher Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 55. Diasorin SPA Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 56. Sysmex Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 57. Biomerieux Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 58. QIAGEN Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 59. Agilent Technologies Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 60. Cnpair Biotech Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 61. Diagvita Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 62. Enriching Biotechnology Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30V16581

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11O6178

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7R6277

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9I8785

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions